Titan Pharmaceuticals to raise $5.5M in stock and pre-funded warrant offering

Feb. 02, 2022 9:08 AM ETTitan Pharmaceuticals, Inc. (TTNP)By: Khyathi Dalal, SA News Editor
  • Titan Pharmaceuticals (NASDAQ:TTNP) trades 3.9% lower premarket after it entered into a securities purchase agreement with a single institutional investor to purchase 3.37M shares in a registered direct offering priced at-the-market.
  • In a concurrent private placement, Titan has also agreed to issue and sell to the investor 1.29M pre-funded warrants, at the same purchase price as in the registered direct offering.
  • It has also agreed to issue to the investor in a concurrent private placement unregistered warrants to purchase up to 4.66M shares.
  • The combined offering price of each share or pre-funded warrant and each warrant will be $1.18.
  • Warrants will be immediately exercisable, will expire on the 5-year and six month anniversary of the issuance date and will have an exercise price of $1.14/share.
  • Gross proceeds of both offerings is expected to be ~$5.5M.
  • The offerings are expected to close on or about Feb.4.

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.